Multidisciplinary

Top Medical News
What are the risk factors for severe infections in hospitalized SLE patients?
8 hours ago
Among hospitalized patients with systemic lupus erythematosus (SLE), factors such as low immunoglobulin, anti-dsDNA antibody positivity, and cyclophosphamide use contribute to an increased risk of recurrent severe infections, according to a study.
Gene profiling of skin lesions improves diagnosis of allergic contact dermatitis
13 hours ago
Analysing molecular signatures from active skin lesions aids in the stratification of patients with contact dermatitis (CD) and helps identify those with allergic CD, suggests a study.
Novel stent works wonders for adults with intracranial aneurysm
Stephen Padilla, 14 hours ago
Application of the modified Alpha stent, an intracranial closed-cell stent with a unique mesh design, delivers satisfactory outcomes in coil embolization of unruptured distal internal carotid artery (ICA) aneurysms, reports a study. Its recent adjustment facilitates a less complicated delivery and deployment.
Microvascular endothelial dysfunction may predict albuminuria in Asians with T2D
15 hours ago
The risk for chronic kidney disease (CKD) progression is higher for people with CKD and normal albuminuria, reveals a study, adding that such risk increases with higher levels of albuminuria.
LDL-C lowering with bempedoic acid reduces cardiovascular events in high-risk population
20 hours ago
The use of bempedoic acid helps lower low-density lipoprotein cholesterol (LDL-C) levels and subsequently reduce cardiovascular events in individuals at high cardiovascular risk, according to the CLEAR* Outcomes trial.
Olezarsen reduces triglyceride levels in adults with hypertriglyceridemia
Elaine Soliven, Yesterday

Monthly administration of olezarsen 50 or 80 mg significantly reduced triglyceride levels in patients with predominantly moderate hypertriglyceridemia (HTG) and elevated cardiovascular (CV) risk, according to the Bridge-TIMI 73a trial presented at ACC.24.

Surgery beneficial to select older adults with epilepsy
Yesterday
Epilepsy surgery may hold promise for carefully selected patients past the age of 50 years, according to a study.
Special Reports
Nirmatrelvir reduces the risk of long COVID
05 Mar 2024

Post-COVID condition, also known as long COVID, is a serious public health problem affecting millions of people around the world.1

COVID-19, influenza, death, hospital admission, adverse outcome
07 Feb 2024
A comparative analysis has shown that COVID-19 is distinctly more severe than seasonal influenza, with significantly increased long-term risks of adverse health outcomes and burdens.1
fenofibrate, metabolic syndrome, statins, omega-3 fatty acids, MACE
05 Feb 2024
A nationwide population-based cohort study in South Korea compared the effectiveness of omega-3 fatty acids and fenofibrate for reducing major adverse cardiovascular events (MACE) in individuals with metabolic syndrome (≥30 years) on statin therapy.1
COVID-19, nirmatrelvir, ritonavir, mRNA vaccine, Omicron, COPD, CDC, WHO
Dr. Chan Kwok Wai Adrian, Prof. Yang Kuang-Yao, 10 Jan 2024
At the 27th Congress of the Asian Pacific Society of Respirology (APSR) 2023, a Pfizer-sponsored symposium addressed the evolving challenges of COVID-19, particularly for patients with pre-existing respiratory conditions. Chaired by Dr Chan Kwok Wai Adrian, a renowned respiratory physician and intensivist from Mount Elizabeth Novena Hospital, Singapore, and featuring insights from Professor Yang Kuang-Yao of National Yang Ming Chiao Tung University, Taipei, Taiwan, the symposium focused on the disease’s impact, treatment guidelines, regional management strategies, and the role of nirmatrelvir/ritonavir, a new oral combination pill, in the treatment of COVID-19.
Challenged Growth Concept and Nutritional Strategy in Indonesia
30 Oct 2023
Scientific meeting event with theme “Beyond Borders: Unlocking New Insight on Early Life Development” was held by Department of Child Health, Universitas Indonesia, supported by Nutricia Sarihusada for two days, September 2nd-3rd, 2023 at Holiday Inn Kemayoran Hotel, Jakarta. There were three classes with different main topics and various speakers from national and international speakers. The first class’s main topic was “Allergy and Immunology Concept and Update”, the second was “GI Health Concept and Update”, and the third was “Challenged Growth Concept and Update”.
Optimizing Child Immunity & Allergy Management in Indonesia: Post-Pandemic Update
30 Oct 2023
Scientific meeting event “Beyond Borders: Unlocking New Insight on Early Life Development” was held by Department of Child Health, Faculty of Medicine, Universitas Indonesia, supported by Nutricia Sarihusada for two days, September 2nd-3rd, 2023 at Holiday Inn Kemayoran Hotel, Jakarta. There were three classes with main topics in Allergy and Immunology, Gastrointestinal Health, and Nutrition brought by various speakers from national and international speakers. This article is focusing on Allergy and Immunology Concept and Update.
Discovering the Role of Gut Microbiota in Gastrointestinal Health: Current Updates
30 Oct 2023
In the field of children’s healthcare, there has recently been a growing interest in the role of gut microbiota and its impact on gastrointestinal health, particularly during the crucial first 1,000 days of a child’s life. To support pediatricians in delivering exceptional care for children, an engaging two-day scientific meeting titled “Beyond Borders: Unlocking New Insight on Early Life Development” was held by Department of Child Health, Faculty of Medicine, Universitas Indonesia; supported by Nutricia Sarihusada. This event was held at the Holiday Inn Kemayoran Hotel on September 2-3, 2023 and focused on three critical areas: Allergy & Immunology, Gastrointestinal (GI) Health, and Nutrition & Metabolism in children.
Conference Reports
Olezarsen reduces triglyceride levels in adults with hypertriglyceridemia
Elaine Soliven, 19 Apr 2024

Monthly administration of olezarsen 50 or 80 mg significantly reduced triglyceride levels in patients with predominantly moderate hypertriglyceridemia (HTG) and elevated cardiovascular (CV) risk, according to the Bridge-TIMI 73a trial presented at ACC.24.

Injectable atezolizumab favoured over intravenous infusion
Jairia Dela Cruz, 18 Apr 2024
Nonsmall cell lung cancer (NSCLC) patients with high PD-L1 expression appear to show a strong preference for receiving atezolizumab subcutaneously rather than intravenously.
Amivantamab plus chemo tied to better outcomes in NSCLC
Stephen Padilla, 17 Apr 2024
Treatment with amivantamab (ami) in combination with chemotherapy (chemo) results in substantially longer time to treatment discontinuation (TTD), time to subsequent therapy (TTST), and progression-free survival (PFS) after first subsequent therapy (PFS2) in patients with EGFR-mutant advanced nonsmall cell lung cancer (NSCLC) following progression on osimertinib, as shown in a postprogression analysis.
Second-hand smoke may up risk of AF
Elvira Manzano, 13 Apr 2024
 Exposure to second-hand tobacco smoke may increase the risk of developing atrial fibrillation (AF), as shown in a population-based cohort study using the UK Biobank database.
Apixaban cheaper, on par with enoxaparin as VTE prophylaxis in gynaecologic cancer patients
Stephen Padilla, 12 Apr 2024
Patients with gynaecologic cancer who used apixaban for postoperative venous thromboembolism (VTE) prophylaxis achieve similar 90-day and lower 30-day rates of VTE when compared with those who used enoxaparin, reports a study presented at SGO 2024.
Maintenance fuzuloparib prolongs survival in ovarian cancer
Stephen Padilla, 12 Apr 2024
Maintenance therapy with fuzuloparib results in significant improvements in progression-free survival (PFS) in patients newly diagnosed with advanced ovarian cancer, who showed response to first-line platinum-based chemotherapy (PBC), reports a study (FZOCUS-1) presented at SGO 2024.
Mandibular device on par with CPAP for BP lowering in OSA patients
Audrey Abella, 12 Apr 2024
In the CRESCENT trial, a mandibular advancement device (MAD) was noninferior to a continuous positive airway pressure (CPAP) machine for reducing 24-hr mean arterial blood pressure (MBP) in individuals with obstructive sleep apnoea (OSA), uncontrolled hypertension, and high cardiovascular (CV) risk.